Similarly, SOX2 expression levels were increased in higher grade gliomas compared with Grade I samples, consistent with the expression trend of MRPs (Fig. 3c, d), and the expression level was higher in the glioma cell lines when compared with NHA (Fig. 3e). Here, SOX2 is linked to glioma.